Avalo Therapeutics (AVTX) EPS (Basic) (2014 - 2026)
Avalo Therapeutics (AVTX) posted EPS (Basic) of -$0.98 for Q1 2026, up 4.61% on a QoQ basis from -$1.02 in Q4 2025, and up 21.93% year-over-year from -$0.8 in Q1 2025.
Avalo Therapeutics (AVTX) EPS (Basic) (2014 - 2026) Analysis & Trends
Avalo Therapeutics' EPS (Basic) history runs 12 years deep, the most recent figure standing at -$0.98 for Q1 2026.
- Quarterly EPS (Basic) rose 21.93% year-over-year to -$0.98 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.21 (down 160.7% YoY) and the FY2025 annual result came in at -$5.84, up 26.44% from the prior year.
- EPS (Basic) was -$0.98 for Q1 2026 at Avalo Therapeutics, up from -$1.02 in the prior quarter.
- Across five years, EPS (Basic) topped out at $95.21 in Q2 2024 and bottomed at -$203.65 in Q1 2023.
- A 4-year average of -$35.2 and a median of -$2.19 in 2025 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2024 — EPS (Basic) surged 167.71% — and 2025, when it slumped 152.66%.
- Avalo Therapeutics' EPS (Basic) stood at -$29.41 in 2023, then surged by 72.85% to -$7.98 in 2024, then jumped by 87.18% to -$1.02 in 2025, then advanced by 4.61% to -$0.98 in 2026.
- Business Quant data shows AVTX's EPS (Basic) at -$0.98 in Q1 2026, -$1.02 in Q4 2025, and -$2.19 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Avalo Therapeutics | 1.04 Mn | 1.04 Mn | - | -0.98 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.98 |
| Dec 31, 2025 | -1.02 |
| Sep 30, 2025 | -2.19 |
| Jun 30, 2025 | -1.92 |
| Mar 31, 2025 | -1.25 |
| Dec 31, 2024 | -7.98 |
| Sep 30, 2024 | 4.15 |
| Jun 30, 2024 | 95.21 |
| Mar 31, 2024 | -141.14 |
| Dec 31, 2023 | -29.41 |
| Sep 30, 2023 | -26.81 |
| Jun 30, 2023 | -140.62 |
| Mar 31, 2023 | -203.65 |
| Dec 31, 2021 | -111.49 |
| Sep 30, 2021 | 6.29 |
| Jun 30, 2021 | 5.71 |
| Mar 31, 2021 | -8.77 |
| Dec 31, 2020 | 41.30 |
| Sep 30, 2020 | -16.39 |
| Jun 30, 2020 | -37.66 |